ContactContactEnglish
  • Home
  • News
  • Market Data
  • Participants
  • Issuers
  • Investors
  • Profile
 
 

News

 

07.04.2017 Issuers

Successful IPO of Galenica Santé

SIX Swiss Exchange attracts a great deal of interest in the IPO of Galenica Santé.

Galenica Santé AG (GALE), a business unit of Galenica AG (new symbol: VIFN*), was listed today as an independent company on SIX Swiss Exchange (IPO video). Galenica Santé is a leading provider of products and services in Switzerland for health, beauty and well-being, and operates the largest network of pharmacies nationwide.

"We are pleased that Galenica Santé has taken this step and has kicked off the IPO season with such a large and successful listing," says Chris Landis, Division CEO SIX Swiss Exchange. "This demonstrates how attractive Switzerland is as a listing location for companies in this sector. We offer them an ideal environment for raising capital including access to a well-capitalized group of international and Swiss investors."

Second-largest IPO since 2006

The IPO consists of 42'391'300 ordinary registered shares plus an overallotment option, granted to the banking consortium, of up to 6'358'700 shares. The opening price was CHF 43.00. This corresponds to a total market capitalization of CHF 2.15 billion. Galenica Santé AG will be listed in the "International Reporting Standard" and admitted to the SPI®. The listing of Galenica Santé marks the second-largest IPO on SIX Swiss Exchange in the last ten years after Sunrise AG in 2015 and the largest IPO in Europe in 2017 year to date.



IPO paves the way for further implementation of the strategy

Galenica had anticipated the vision to separate the Group in two independent listed entities. The IPO of Galenica Santé will enable the company to develop in an even more focused way. It will also give investors the opportunity to own separate pure-play entities.

"Our range of offerings and services for all participants in the healthcare market makes us the leading health services provider in Switzerland. Building on our strengths, the IPO on SIX Swiss Exchange will enable Galenica Santé to pursue its strategy in an even more focused way. We and our employees have the opportunity to further develop our unique position - with our own and partner pharmacies, our own brands and partner products, and our expertise in logistics", explains Jean-Claude Clémençon, CEO Galenica Santé.

Numerous benefits for equity issuers

A listing on SIX Swiss Exchange provides companies with access to strongly capitalized Swiss and international investors. In addition, we make things as simple as possible for them with first-class, needs-oriented services, allowing them to efficiently raising capital and therefore achieving sustainable growth. Our appeal extends far beyond the borders of Switzerland.

A comprehensive overview and helpful information on all topics relevant to going public on SIX Swiss Exchange can be found in the corresponding Going Public Guide. Further information on our range of services for issuers can be found on our website.

*The Valor symbol of Galenica will change from GALN to VIFN on 7 April 2017.

Contact

Show all news